Nanomaterials in Personalized Medicine: Global Markets

Report Highlights

The global theranostic nanomaterial market was estimated to total nearly $106 billion in 2011 and $112 billion in 2012. The market should total nearly $188 billion by 2017, and have a five-year compound annual growth rate (CAGR) of 10.8%.

This report provides:

• An overview of the global market for nanomaterials in medicine used for both therapy and diagnostics, or theranostics.
• Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
• Discussion of the advantages of nanoscale materials, such as in the fabrication of nano-machines that can deliver their cargo (a drug) to a precise location (for instance, the tumor tissue of a specific organ) so that healthy tissues are minimally affected, and in the fabrication of nano-drugs, diagnosis in vivo and therapeutic applications.
• Examination of the role of theranostics in oncology, immunodeficiencies, and cardiovascular and neuro disorders.
• Identification of the types of theranostic agents, such as gold-based, magnetic, polymeric, silica-based, carbon, composite, and lyposome nanomaterials.

SCOPE OF THE REPORT

Blockbuster and one–size-fits-all drugs are slowly exiting the market to make room for the era of personalized medicine. Theranostics, which is the fusion of therapeutics and diagnostics, is the foundation of personalized medicine in which specific therapies are tailored to patients to treat diseases based on their genetic makeups and/or to determine which therapies will have the fewest side effects. Nanotechnology will play a pivotal role in this revolution, and the global market for nanomaterials used in theranostics will be more than $187 billion in 2017, increasing at a compound annual growth rate (CAGR) of 10.8%

Monoclonal antibodies will comprise the largest segment for the biologic nanomaterials, and liposome will be the largest segment for non-biologic nanomaterials. Other nanomaterials discussed in this report include fullerene C60, carbon nanotubes, quantum dots, gold nanoparticles and proteins.

Profiles of key market players and small startups are also included. Major products that generate the largest revenues, as well as the most-valuable R&D products that will come on the market up to 2017 are provided.

In-depth competitive market analysis is discussed, with examples of how new products will enter the market or how existing products will survive or perish. The report also includes a very detailed description of current and future technologies for the preparation of nanomaterials in theranostics.

ANALYST CREDENTIALS

Alessandro Varotto holds a Master’s degree in Industrial Chemistry and a PhD in Chemistry with a specialty in Nanotechnology and Materials Science. Dr. Varotto has worked as a research scientist in both academic and industry environments. He is the author of 15 peer-reviewed research articles, a patent, a book and dozens of technical papers in the field of life science. His expertise includes chemistry and nanomaterials with medical applications.